136 related articles for article (PubMed ID: 29221164)
1. Inhibition of X-linked inhibitor of apoptosis protein suppresses tumorigenesis and enhances chemosensitivity in anaplastic thyroid carcinoma.
Liu Y; Zhang B; Shi T; Qin H
Oncotarget; 2017 Nov; 8(56):95764-95772. PubMed ID: 29221164
[TBL] [Abstract][Full Text] [Related]
2. Aberrant l1 cell adhesion molecule affects tumor behavior and chemosensitivity in anaplastic thyroid carcinoma.
Kim KS; Min JK; Liang ZL; Lee K; Lee JU; Bae KH; Lee MH; Lee SE; Ryu MJ; Kim SJ; Kim YK; Choi MJ; Jo YS; Kim JM; Shong M
Clin Cancer Res; 2012 Jun; 18(11):3071-8. PubMed ID: 22472175
[TBL] [Abstract][Full Text] [Related]
3. MiR-618 inhibits anaplastic thyroid cancer by repressing XIAP in one ATC cell line.
Cheng Q; Zhang X; Xu X; Lu X
Ann Endocrinol (Paris); 2014 Sep; 75(4):187-93. PubMed ID: 25145559
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical detection of X-linked inhibitor of apoptosis (XIAP) in neoplastic and other thyroid disorders.
Xiao GQ; Unger PD; Burstein DE
Ann Diagn Pathol; 2007 Aug; 11(4):235-40. PubMed ID: 17630106
[TBL] [Abstract][Full Text] [Related]
5. Laminin-5γ-2 (LAMC2) is highly expressed in anaplastic thyroid carcinoma and is associated with tumor progression, migration, and invasion by modulating signaling of EGFR.
Garg M; Kanojia D; Okamoto R; Jain S; Madan V; Chien W; Sampath A; Ding LW; Xuan M; Said JW; Doan NB; Liu LZ; Yang H; Gery S; Braunstein GD; Koeffler HP
J Clin Endocrinol Metab; 2014 Jan; 99(1):E62-72. PubMed ID: 24170107
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of S100A4 blocks growth and metastasis of anaplastic thyroid cancer cells in vitro and in vivo.
Zhang K; Yu M; Hao F; Dong A; Chen D
Cancer Biomark; 2016 Sep; 17(3):281-291. PubMed ID: 27802204
[TBL] [Abstract][Full Text] [Related]
7. Antitumor effects of proteasome inhibition in anaplastic thyroid carcinoma.
Altmann A; Markert A; Askoxylakis V; Schöning T; Jesenofsky R; Eisenhut M; Haberkorn U
J Nucl Med; 2012 Nov; 53(11):1764-71. PubMed ID: 23055533
[TBL] [Abstract][Full Text] [Related]
8. miR-544 inhibits the migration and invasion of anaplastic thyroid cancer by targeting Yin Yang-1.
Wang F; Li Z; Sun B
Oncol Lett; 2019 Mar; 17(3):2983-2992. PubMed ID: 30854076
[TBL] [Abstract][Full Text] [Related]
9. Macrophage-Induced Carboxypeptidase A4 Promotes the Progression of Anaplastic Thyroid Cancer.
Choi YS; Jeon MJ; Doolittle WKL; Song DE; Kim K; Kim WB; Kim WG
Thyroid; 2024 May; ():. PubMed ID: 38666696
[No Abstract] [Full Text] [Related]
10. Human anaplastic thyroid carcinoma cells are sensitive to NK cell-mediated lysis via ULBP2/5/6 and chemoattract NK cells.
Wennerberg E; Pfefferle A; Ekblad L; Yoshimoto Y; Kremer V; Kaminskyy VO; Juhlin CC; Höög A; Bodin I; Svjatoha V; Larsson C; Zedenius J; Wennerberg J; Lundqvist A
Clin Cancer Res; 2014 Nov; 20(22):5733-44. PubMed ID: 25212604
[TBL] [Abstract][Full Text] [Related]
11. Aberrant lipid metabolism in anaplastic thyroid carcinoma reveals stearoyl CoA desaturase 1 as a novel therapeutic target.
von Roemeling CA; Marlow LA; Pinkerton AB; Crist A; Miller J; Tun HW; Smallridge RC; Copland JA
J Clin Endocrinol Metab; 2015 May; 100(5):E697-709. PubMed ID: 25675381
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Aurora kinase inhibition as a new therapeutic strategy in anaplastic and poorly differentiated follicular thyroid cancer.
Wunderlich A; Fischer M; Schlosshauer T; Ramaswamy A; Greene BH; Brendel C; Doll D; Bartsch D; Hoffmann S
Cancer Sci; 2011 Apr; 102(4):762-8. PubMed ID: 21214672
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-212 inhibits the proliferation, migration and invasion of renal cell carcinoma by targeting X-linked inhibitor of apoptosis protein (XIAP).
Gu C; Wang Z; Jin Z; Li G; Kou Y; Jia Z; Yang J; Tian F
Oncotarget; 2017 Nov; 8(54):92119-92133. PubMed ID: 29190902
[TBL] [Abstract][Full Text] [Related]
14. KAT5 Inhibitor NU9056 Suppresses Anaplastic Thyroid Carcinoma Progression through c-Myc/miR-202 Pathway.
Xu W; Xie L; Yang Y; Xu J; Cai S; Tian Y
Int J Endocrinol; 2022; 2022():2014568. PubMed ID: 37342240
[TBL] [Abstract][Full Text] [Related]
15. Targeting signal transducer and activator of transcription 3 pathway by cucurbitacin I diminishes self-renewing and radiochemoresistant abilities in thyroid cancer-derived CD133+ cells.
Tseng LM; Huang PI; Chen YR; Chen YC; Chou YC; Chen YW; Chang YL; Hsu HS; Lan YT; Chen KH; Chi CW; Chiou SH; Yang DM; Lee CH
J Pharmacol Exp Ther; 2012 May; 341(2):410-23. PubMed ID: 22328572
[TBL] [Abstract][Full Text] [Related]
16. MiR-125b inhibits anaplastic thyroid cancer cell migration and invasion by targeting PIK3CD.
Bu Q; You F; Pan G; Yuan Q; Cui T; Hao L; Zhang J
Biomed Pharmacother; 2017 Apr; 88():443-448. PubMed ID: 28122310
[TBL] [Abstract][Full Text] [Related]
17. BRMS1 downregulation is a poor prognostic biomarker in anaplastic thyroid carcinoma patients.
Wu Y; Wang H; Zhi J; Hu L; Hou X; Ruan X; Zheng X; Liu H; Gao M
Onco Targets Ther; 2019; 12():6937-6945. PubMed ID: 31695409
[TBL] [Abstract][Full Text] [Related]
18. Dual inhibition of HDAC and EGFR signaling with CUDC-101 induces potent suppression of tumor growth and metastasis in anaplastic thyroid cancer.
Zhang L; Zhang Y; Mehta A; Boufraqech M; Davis S; Wang J; Tian Z; Yu Z; Boxer MB; Kiefer JA; Copland JA; Smallridge RC; Li Z; Shen M; Kebebew E
Oncotarget; 2015 Apr; 6(11):9073-85. PubMed ID: 25940539
[TBL] [Abstract][Full Text] [Related]
19. An orthotopic model of anaplastic thyroid carcinoma in athymic nude mice.
Kim S; Park YW; Schiff BA; Doan DD; Yazici Y; Jasser SA; Younes M; Mandal M; Bekele BN; Myers JN
Clin Cancer Res; 2005 Mar; 11(5):1713-21. PubMed ID: 15755992
[TBL] [Abstract][Full Text] [Related]
20. CXC chemokine receptor 4 expression and function in human anaplastic thyroid cancer cells.
Hwang JH; Hwang JH; Chung HK; Kim DW; Hwang ES; Suh JM; Kim H; You KH; Kwon OY; Ro HK; Jo DY; Shong M
J Clin Endocrinol Metab; 2003 Jan; 88(1):408-16. PubMed ID: 12519884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
